61 related articles for article (PubMed ID: 713173)
1. [The effect of 1alpha-hydroxycholecalciferol on the abnormal calcium metabolism in hemodialysis patients.--Studies on patients showing low serum calcium and high alkaline phosphatase (author's transl)].
Asai K; Ohkura T; Sakamoto N; Kawahara H; Yamazaki C
Nihon Jinzo Gakkai Shi; 1978 Sep; 20(9):967-77. PubMed ID: 713173
[No Abstract] [Full Text] [Related]
2. 1alpha-hydroxycholecalciferol: a promising therapeutic approach for renal osteodystrophy.
Gotloib L; Mines M; Mazur Y; Sklan D; Garmizo AL; Jancu J; Israeli M; Malul M
Isr J Med Sci; 1978 Jul; 14(7):731-5. PubMed ID: 681163
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of renal osteopathy with 5,6-trans-25-hydroxycholecalciferol (author's transl)].
Kraft D; Schaefer K; Grigoleit HG; Offermann G; von Herrath D; Delling G
Dtsch Med Wochenschr; 1979 Nov; 104(48):1706-10. PubMed ID: 520165
[TBL] [Abstract][Full Text] [Related]
4. [The effect of alphacalcidol on calcium and phosphate metabolism in patients treated with hemodialysis].
Veljković S; Raicević R; Cukaranović R; Ralenković S; Stojanović M; Kostić S; Djordjević V; Radenković M
Srp Arh Celok Lek; 1996; 124 Suppl 1():117-8. PubMed ID: 9102869
[TBL] [Abstract][Full Text] [Related]
5. [The characteristics with regard to the serum alkaline phosphatase in patients under longterm hemodialysis (author's transl)].
Matsuda Y; Kijima Y; Sasaoka T; Kanayama M
Rinsho Byori; 1978 May; 26(5):451-6. PubMed ID: 671797
[No Abstract] [Full Text] [Related]
6. 1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.
Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; De Luca HF
Calcif Tissue Res; 1976 Aug; 21 Suppl():226-35. PubMed ID: 782662
[No Abstract] [Full Text] [Related]
7. Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism.
Torer N; Torun D; Torer N; Micozkadioglu H; Noyan T; Ozdemir FN; Haberal M
Transplant Proc; 2009 Nov; 41(9):3642-6. PubMed ID: 19917359
[TBL] [Abstract][Full Text] [Related]
8. 1alpha-hydroxycholecalciferol. Long-term treatment of patients with uraemic osteodystrophy.
Nielsen SP; Binderup E; Godtfredsen WO; Jensen H; Ladefoged J
Nephron; 1976; 16(5):359-70. PubMed ID: 1264309
[TBL] [Abstract][Full Text] [Related]
9. [Long-term treatment of renalosteodystrophy with 1 alpha-hydroxycholecalciferol].
Marco Franco JE; Alarcón Zurita A; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Dalmau Diana M
Rev Clin Esp; 1982 Jan; 164(1):33-5. PubMed ID: 7071401
[No Abstract] [Full Text] [Related]
10. [The effect of vitamin D2 supplementation on hypocalcemia in patients under chronic hemodialysis (author's transl)].
Kaneda H; Tobinai K; Murata T; Maeda T; Matsumoto J; Haruyama T; Imawari M
Nihon Jinzo Gakkai Shi; 1980 Jun; 22(6):679-87. PubMed ID: 6970844
[No Abstract] [Full Text] [Related]
11. [Clinical estimation of 1-alpha-hydroxycholecalciferol in treatment of patients with chronic renal failure].
Chodorowski Z; Rutkowski B; Wielgosz A; Chamienia A; Sulima-Gillow A; Manitius A
Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1093-5. PubMed ID: 1305733
[TBL] [Abstract][Full Text] [Related]
12. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of phosphate-binders in patients on regular hemodialysis (author's transl)].
Gahl G; Hopfenmüller W; Baethke R
Med Klin; 1978 May; 73(19):710-4. PubMed ID: 651760
[No Abstract] [Full Text] [Related]
14. [A study on calcium metabolism in renal failure--clinical aspects and treatment (author's transl)].
Asai K; Watanabe Y; Ohkura T; Sakamoto N
Nihon Jinzo Gakkai Shi; 1980 Nov; 22(11):1505-21. PubMed ID: 7206329
[No Abstract] [Full Text] [Related]
15. Effect of 25-hydroxycholecalciferol (25-HCC) on intestinal absorption of 47Ca in four cases of iatrogenic Cushing's syndrome.
Caniggia A; Gennari C
Helv Med Acta; 1973 Oct; 37(4):221-5. PubMed ID: 4357902
[No Abstract] [Full Text] [Related]
16. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
Broulík P; Hrubý M
Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
[TBL] [Abstract][Full Text] [Related]
17. [The index of leukocyte alkaline phosphatase in patients with hemodialysis (author's transl)].
Abbrederis K; Schmalzl F; Dittrich P
Med Klin; 1977 Feb; 72(6):212-5. PubMed ID: 190525
[TBL] [Abstract][Full Text] [Related]
18. Plasma 25-hydroxycholecalciferol in chronic renal failure.
Bayard F; Bec P; Ton That H; Louvet JP
Eur J Clin Invest; 1973 Dec; 3(6):447-50. PubMed ID: 4778374
[No Abstract] [Full Text] [Related]
19. Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy.
Pylypchuk G; Oreopoulos DG; Wilson DR; Harrison JE; McNeill KG; Meema HE; Ogilvie R; Sturtridge WC; Murray TM
Can Med Assoc J; 1978 Mar; 118(6):635-8. PubMed ID: 418865
[TBL] [Abstract][Full Text] [Related]
20. Effects of 25-hydroxycholecalciferol on calcium metabolism in chronic renal failure.
Letteri JM; Kleinman LM; Ellis KN; Caselnova R; Akhtar M; Cohn SH
Adv Exp Med Biol; 1977; 81():591-601. PubMed ID: 899943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
